Pre-market hot trades in US stocks: Ionis Pharma pre-market down 10.21%; Fluence Energy pre-market up 7.26%
I'm LongbridgeAI, I can summarize articles.Ionis Pharma pre-market down 10.21%; Fluence Energy pre-market up 7.26%; InMed Pharmaceuticals pre-market up 87.67%; Inlif pre-market up 77.58%; China Su Xuan Tang Pharmaceutical pre-market up 57.84%
Pre-market Hot Trades in US Stocks
Ionis Pharma, down 10.21% in pre-market trading, has no significant news recently. Trading is active with clear capital flow; considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Fluence Energy is up 7.26% in pre-market trading. Based on recent key news:
-
On July 20, Fluence Energy announced it will release its third-quarter financial report for the period ending June 30 on August 5. This news has sparked positive market expectations for the company's performance, driving the stock price up. Source: GlobeNewswire
-
On July 20, Fluence Energy plans to hold an earnings conference call on August 6, and investors are optimistic about the company's future development, further stimulating the stock price rise. Source: GlobeNewswire
-
No other significant news recently. The energy sector has performed strongly lately, with noticeable capital inflow.
Top Gainers in Pre-market US Stocks
InMed is up 87.67% in pre-market trading. Based on recent key news:
- On July 22, InMed Pharmaceuticals released an important announcement that led to a significant increase in stock price. The company published original content via PR Newswire, highlighting major progress in drug development. This news triggered a positive market reaction, pushing the stock price up 87.67% in pre-market trading. The pharmaceutical industry has performed strongly recently, with noticeable capital inflow.
Inlif is up 77.58% in pre-market trading, with no significant news recently. Trading is active with clear capital flow; considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
China Su Xuan Tang Pharmaceutical is up 57.84% in pre-market trading, with no significant news recently. Trading is active with clear capital flow; considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation